Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Camlin Fine Sciences Limited ( (IN:CAMLINFINE) ) just unveiled an update.
Camlin Fine Sciences has initiated a postal ballot process to seek shareholder approval for increasing its authorised share capital from ₹21.5 crore to ₹25 crore, through an expansion in the number of equity shares of ₹1 each. The move, conducted via remote e-voting provided by NSDL between April 8 and May 7, 2026, aims to amend the company’s Memorandum of Association and will give the company additional headroom for future equity issuance, potentially supporting growth plans and enhancing financial flexibility for stakeholders.
More about Camlin Fine Sciences Limited
Camlin Fine Sciences Limited operates in the specialty chemicals sector, focusing on fine chemicals and related products for various industrial applications. Listed on both BSE and NSE, the company targets a broad base of institutional and retail investors through its equity shares of ₹1 each.
Average Trading Volume: 60,760
Technical Sentiment Signal: Sell
Current Market Cap: 19.83B INR
See more insights into CAMLINFINE stock on TipRanks’ Stock Analysis page.